EPO and vascular disorder: In EPO group, the most commonly reported TEAEs by SOC were; respiratory, thoracic and mediastinal disorders (22.2%), general disorders and administration site conditions (15.9%), vascular disorders (12.7%), gastrointestinal disorders (11.1%), infections and infestations (9.5%), and investigations (7.9%).